use of oct in amd clinical trials
Published 7 years ago • 223 plays • Length 7:12Download video MP4
Download video MP3
Similar videos
-
7:33
use of oct and octa in diabetic retinopathy clinical trials
-
10:04
innovation in clinical trials – using ai in oct scans
-
7:16
a history of oct-a (ois@asrs 2016)
-
6:23
lumithera’s novel light-based treatment for dry amd
-
22:51
ois retina 2022: how to execute new treatments for dry amd and ga
-
35:03
combination therapies in amd and dme
-
6:22
hemera has dry amd in its sights
-
22:39
spotlight on dry amd and ga panel
-
1:08:32
targeting mitochondria to treat age-related macular degeneration, deborah a. ferrington, phd - uci
-
36:14
ois podcast ep #381: approachable regenerative medicine
-
29:01
using artificial intelligence to diagnose & treat amd, professor pearse keane
-
7:33
diabetic retinopathy, amd, retina, ophthalmology, innovation
-
7:32
ohr set to begin phase iii trials for wet amd (ois@aao 2016)
-
5:00
translatum medicus preps for first dry amd trial
-
6:49
ois drug delivery innovation showcase - eyevensys
-
49:12
ois podcast episode #346: the potential of entire eye oct imaging
-
56:47
the abcs of oct: amd, dme and retinal vascular disease
-
7:54
ois drug delivery innovation showcase - graybug
-
7:02
reneuron: using hrpcs to treat inherited retinal degenerative diseases
-
11:28
genetic and regenerative therapy overview presentation at ophthalmology innovation summit 2019
-
8:54
adverum biotechnologies - public company showcase at ophthalmology innovation summit @ asrs 2019
-
9:09
novartis’ sauer updates on amd trial, sees bright future for ophthalmology innovation